Understanding OUR Cytokine-Based Immunotherapy Candidates Our Commitment extends to advancing a robust portfolio of programs aimed toward increasing the horizons of cytokine-based immunotherapy, especially for cancers where therapy choices remain limited. Make use of the links below to learn extra about our portfolio of cytokine-based immunotherapy candidates. Check out https://financefeeds.com/bny-mellon-appoints-carolyn-weinberg-to-lead-innovation/